DAPAGLIFLOZIN
- Product NDC
- 66993-457
- 11-digit product format
- 669930457
- Labeler code
- 66993
- Product ID
- 66993-457_4cdea416-6da9-411e-aa5a-ba78fc388844
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DAPAGLIFLOZIN
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Prasco Laboratories
- Application
- NDA202293
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2024-01-03
- Substance
- DAPAGLIFLOZIN PROPANEDIOL
- Active strength
- 10 mg/1
- Pharmacologic classes
- Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N202293-001 | FARXIGA | DAPAGLIFLOZIN | 5MG | TABLET / ORAL | AB | RLD | 2014-01-08 |
| N202293-002 | FARXIGA | DAPAGLIFLOZIN | 10MG | TABLET / ORAL | AB | RLD, RS | 2014-01-08 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N202293-001 | AB |
| N202293-002 | AB |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N202293-001 | 6515117 | 2025-10-04 | U-2139 | Drug substance, Drug product | 2014-02-05 |
| N202293-001 | 6515117 | 2025-10-04 | U-493 | Drug substance, Drug product | 2014-02-05 |
| N202293-001 | 6515117*PED | 2026-04-04 | Pediatric extension | ||
| N202293-001 | 8329648 | 2026-08-18 | U-2139 | 2017-11-15 | |
| N202293-001 | 8329648 | 2026-08-18 | U-2212 | 2017-11-15 | |
| N202293-001 | 8329648 | 2026-08-18 | U-2213 | 2017-11-15 | |
| N202293-001 | 8906851 | 2026-08-18 | U-2139 | 2017-11-15 | |
| N202293-001 | 8329648*PED | 2027-02-18 | Pediatric extension | ||
| N202293-001 | 8906851*PED | 2027-02-18 | Pediatric extension | ||
| N202293-001 | 8501698 | 2027-06-20 | U-493 | Drug product | 2014-02-05 |
| N202293-001 | 8501698*PED | 2027-12-20 | Pediatric extension | ||
| N202293-001 | 8221786 | 2028-03-21 | Drug product | 2014-02-05 | |
| N202293-001 | 8361972 | 2028-03-21 | U-2139 | 2014-02-05 | |
| N202293-001 | 8361972 | 2028-03-21 | U-493 | 2014-02-05 | |
| N202293-001 | 8716251 | 2028-03-21 | Drug product | 2014-06-02 | |
| N202293-001 | 7851502 | 2028-08-19 | Drug product | 2014-02-05 | |
| N202293-001 | 8221786*PED | 2028-09-21 | Pediatric extension | ||
| N202293-001 | 8361972*PED | 2028-09-21 | Pediatric extension | ||
| N202293-001 | 8716251*PED | 2028-09-21 | Pediatric extension | ||
| N202293-001 | 7851502*PED | 2029-02-19 | Pediatric extension | ||
| N202293-001 | 7919598 | 2029-12-16 | Drug substance | 2014-02-05 | |
| N202293-001 | 8721615 | 2030-01-18 | Drug product, Delist requested | 2017-11-15 | |
| N202293-001 | 8685934 | 2030-05-26 | U-1522 | 2014-06-25 | |
| N202293-001 | 7919598*PED | 2030-06-16 | Pediatric extension | ||
| N202293-001 | 8721615*PED | 2030-07-18 | Pediatric extension | ||
| N202293-001 | 8685934*PED | 2030-11-26 | Pediatric extension | ||
| N202293-002 | 6515117 | 2025-10-04 | U-2139 | Drug substance, Drug product | 2014-02-05 |
| N202293-002 | 6515117 | 2025-10-04 | U-493 | Drug substance, Drug product | 2014-02-05 |
| N202293-002 | 6515117*PED | 2026-04-04 | Pediatric extension | ||
| N202293-002 | 8329648 | 2026-08-18 | U-2139 | 2017-11-15 | |
| N202293-002 | 8329648 | 2026-08-18 | U-2212 | 2017-11-15 | |
| N202293-002 | 8329648 | 2026-08-18 | U-2213 | 2017-11-15 | |
| N202293-002 | 8906851 | 2026-08-18 | U-2139 | 2017-11-15 | |
| N202293-002 | 8329648*PED | 2027-02-18 | Pediatric extension | ||
| N202293-002 | 8906851*PED | 2027-02-18 | Pediatric extension | ||
| N202293-002 | 8501698 | 2027-06-20 | U-493 | Drug product | 2014-02-05 |
| N202293-002 | 8501698*PED | 2027-12-20 | Pediatric extension | ||
| N202293-002 | 8221786 | 2028-03-21 | Drug product | 2014-02-05 | |
| N202293-002 | 8361972 | 2028-03-21 | U-2139 | 2014-02-05 | |
| N202293-002 | 8361972 | 2028-03-21 | U-493 | 2014-02-05 | |
| N202293-002 | 8716251 | 2028-03-21 | Drug product | 2014-06-02 | |
| N202293-002 | 7851502 | 2028-08-19 | Drug product | 2014-02-05 | |
| N202293-002 | 8221786*PED | 2028-09-21 | Pediatric extension | ||
| N202293-002 | 8361972*PED | 2028-09-21 | Pediatric extension | ||
| N202293-002 | 8716251*PED | 2028-09-21 | Pediatric extension | ||
| N202293-002 | 7851502*PED | 2029-02-19 | Pediatric extension | ||
| N202293-002 | 7919598 | 2029-12-16 | Drug substance | 2014-02-05 | |
| N202293-002 | 8721615 | 2030-01-18 | Drug product, Delist requested | 2017-11-15 | |
| N202293-002 | 8685934 | 2030-05-26 | U-1522 | 2014-06-25 | |
| N202293-002 | 7919598*PED | 2030-06-16 | Pediatric extension | ||
| N202293-002 | 8721615*PED | 2030-07-18 | Pediatric extension | ||
| N202293-002 | 8685934*PED | 2030-11-26 | Pediatric extension | ||
| N202293-002 | 11826376 | 2039-07-18 | U-3766 | 2023-12-19 | |
| N202293-002 | 12472194 | 2039-07-18 | U-4346 | 2025-12-11 | |
| N202293-002 | 11826376*PED | 2040-01-18 | Pediatric extension | ||
| N202293-002 | 12472194*PED | 2040-01-18 | Pediatric extension | ||
| N202293-002 | 10973836 | 2040-03-09 | U-3127 | 2021-04-21 | |
| N202293-002 | 11903955 | 2040-03-09 | U-3825 | 2024-03-13 | |
| N202293-002 | 10973836*PED | 2040-09-09 | Pediatric extension | ||
| N202293-002 | 11903955*PED | 2040-09-09 | Pediatric extension | ||
| N202293-002 | 12213988 | 2041-04-01 | U-4140 | 2025-03-04 | |
| N202293-002 | 12409186 | 2041-04-01 | U-4140 | 2025-09-29 | |
| N202293-002 | 12213988*PED | 2041-10-01 | Pediatric extension | ||
| N202293-002 | 12409186*PED | 2041-10-01 | Pediatric extension |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N202293-001 | M-298 | 2026-05-08 |
| N202293-001 | PED | 2026-11-08 |
| N202293-001 | NPP | 2027-06-12 |
| N202293-001 | PED | 2027-12-12 |
| N202293-002 | M-298 | 2026-05-08 |
| N202293-002 | PED | 2026-11-08 |
| N202293-002 | NPP | 2027-06-12 |
| N202293-002 | PED | 2027-12-12 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | FARXIGA | 5MG | TABLET / ORAL | RLD | 2014-01-08 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-002 | FARXIGA | 10MG | TABLET / ORAL | RLD, RS | 2014-01-08 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N202293-001 | FARXIGA | 5MG | TABLET / ORAL | RLD | 2014-01-08 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N202293-002 | FARXIGA | 10MG | TABLET / ORAL | RLD, RS | 2014-01-08 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202293-001 | FARXIGA | 5MG | TABLET / ORAL | RLD | 2014-01-08 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202293-002 | FARXIGA | 10MG | TABLET / ORAL | RLD, RS | 2014-01-08 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N202293-001 | FARXIGA | 5MG | TABLET / ORAL | RLD | 2014-01-08 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N202293-002 | FARXIGA | 10MG | TABLET / ORAL | RLD, RS | 2014-01-08 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N202293-001 | FARXIGA | 5MG | TABLET / ORAL | RLD | 2014-01-08 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N202293-002 | FARXIGA | 10MG | TABLET / ORAL | RLD, RS | 2014-01-08 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N202293-001 | FARXIGA | 5MG | TABLET / ORAL | RLD | 2014-01-08 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N202293-002 | FARXIGA | 10MG | TABLET / ORAL | RLD, RS | 2014-01-08 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N202293-001 | FARXIGA | 5MG | TABLET / ORAL | AB | RLD | 2014-01-08 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N202293-002 | FARXIGA | 10MG | TABLET / ORAL | AB | RLD, RS | 2014-01-08 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N202293-001 | FARXIGA | 5MG | TABLET / ORAL | AB | RLD | 2014-01-08 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N202293-002 | FARXIGA | 10MG | TABLET / ORAL | AB | RLD, RS | 2014-01-08 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N202293-001 | FARXIGA | 5MG | TABLET / ORAL | AB | RLD | 2014-01-08 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N202293-002 | FARXIGA | 10MG | TABLET / ORAL | AB | RLD, RS | 2014-01-08 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N202293-001 | FARXIGA | 5MG | TABLET / ORAL | RLD | 2014-01-08 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N202293-002 | FARXIGA | 10MG | TABLET / ORAL | RLD, RS | 2014-01-08 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N202293-001 | FARXIGA | 5MG | TABLET / ORAL | RLD | 2014-01-08 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N202293-002 | FARXIGA | 10MG | TABLET / ORAL | RLD, RS | 2014-01-08 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N202293-001 | FARXIGA | 5MG | TABLET / ORAL | RLD | 2014-01-08 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N202293-002 | FARXIGA | 10MG | TABLET / ORAL | RLD, RS | 2014-01-08 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N202293-001 | FARXIGA | 5MG | TABLET / ORAL | RLD | 2014-01-08 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N202293-002 | FARXIGA | 10MG | TABLET / ORAL | RLD, RS | 2014-01-08 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N202293-001 | FARXIGA | 5MG | TABLET / ORAL | RLD | 2014-01-08 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N202293-002 | FARXIGA | 10MG | TABLET / ORAL | RLD, RS | 2014-01-08 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N202293-001 | FARXIGA | 5MG | TABLET / ORAL | RLD | 2014-01-08 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N202293-002 | FARXIGA | 10MG | TABLET / ORAL | RLD, RS | 2014-01-08 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N202293-001 | FARXIGA | 5MG | TABLET / ORAL | RLD | 2014-01-08 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N202293-002 | FARXIGA | 10MG | TABLET / ORAL | RLD, RS | 2014-01-08 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N202293-001 | FARXIGA | 5MG | TABLET / ORAL | RLD | 2014-01-08 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N202293-002 | FARXIGA | 10MG | TABLET / ORAL | RLD, RS | 2014-01-08 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N202293-001 | FARXIGA | 5MG | TABLET / ORAL | RLD | 2014-01-08 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N202293-002 | FARXIGA | 10MG | TABLET / ORAL | RLD, RS | 2014-01-08 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N202293-001 | FARXIGA | 5MG | TABLET / ORAL | RLD | 2014-01-08 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N202293-002 | FARXIGA | 10MG | TABLET / ORAL | RLD, RS | 2014-01-08 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N202293-001 | FARXIGA | 5MG | TABLET / ORAL | RLD | 2014-01-08 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N202293-002 | FARXIGA | 10MG | TABLET / ORAL | RLD, RS | 2014-01-08 | 6a51e52b5d6a… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N202293-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N202293-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N202293-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N202293-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N202293-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N202293-002 | AB | 1 | 4b0b4de00fa7… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N202293-001 | AB | 1 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N202293-002 | AB | 1 | cb3db0bc1861… |
| 2026-08-01 22:54:32 | 2026-06 | N202293-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N202293-002 | AB | 1 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 9238076 | 2024-04-15 | U-2139 | 2017-11-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8431685 | 2025-04-13 | U-2139 | 2017-11-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8461105 | 2025-04-13 | U-2139 | 2017-11-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 7456254 | 2025-06-30 | U-2139 | 2017-11-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 6515117 | 2025-10-04 | U-493 | Drug substance, Drug product | 2014-02-05 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 6515117 | 2025-10-04 | U-2139 | Drug substance, Drug product | 2014-02-05 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8431685*PED | 2025-10-13 | Pediatric extension | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8461105*PED | 2025-10-13 | Pediatric extension | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 7456254*PED | 2025-12-30 | Pediatric extension | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 6515117*PED | 2026-04-04 | Pediatric extension | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8329648 | 2026-08-18 | U-2213 | 2017-11-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8329648 | 2026-08-18 | U-2139 | 2017-11-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8329648 | 2026-08-18 | U-2212 | 2017-11-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8906851 | 2026-08-18 | U-2139 | 2017-11-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8329648*PED | 2027-02-18 | Pediatric extension | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8906851*PED | 2027-02-18 | Pediatric extension | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8501698 | 2027-06-20 | U-493 | Drug product | 2014-02-05 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8501698*PED | 2027-12-20 | Pediatric extension | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8221786 | 2028-03-21 | Drug product | 2014-02-05 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8361972 | 2028-03-21 | U-2139 | 2014-02-05 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8361972 | 2028-03-21 | U-493 | 2014-02-05 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8716251 | 2028-03-21 | Drug product | 2014-06-02 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 7851502 | 2028-08-19 | Drug product | 2014-02-05 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8221786*PED | 2028-09-21 | Pediatric extension | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8361972*PED | 2028-09-21 | Pediatric extension | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8716251*PED | 2028-09-21 | Pediatric extension | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 7851502*PED | 2029-02-19 | Pediatric extension | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 7919598 | 2029-12-16 | Drug substance | 2014-02-05 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8721615 | 2030-01-18 | Drug product, Delist requested | 2017-11-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8685934 | 2030-05-26 | U-1522 | 2014-06-25 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 7919598*PED | 2030-06-16 | Pediatric extension | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8721615*PED | 2030-07-18 | Pediatric extension | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | 8685934*PED | 2030-11-26 | Pediatric extension | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-002 | 9238076 | 2024-04-15 | U-2139 | 2017-11-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-002 | 8431685 | 2025-04-13 | U-2139 | 2017-11-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-002 | 8461105 | 2025-04-13 | U-2139 | 2017-11-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-002 | 7456254 | 2025-06-30 | U-2139 | 2017-11-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-002 | 6515117 | 2025-10-04 | U-2139 | Drug substance, Drug product | 2014-02-05 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-002 | 6515117 | 2025-10-04 | U-493 | Drug substance, Drug product | 2014-02-05 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-002 | 8431685*PED | 2025-10-13 | Pediatric extension | d8e5a09893c0… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | I-857 | 2024-04-30 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | M-298 | 2026-05-08 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | PED | 2026-11-08 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | NPP | 2027-06-12 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-001 | PED | 2027-12-12 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-002 | I-857 | 2024-04-30 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-002 | M-298 | 2026-05-08 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-002 | PED | 2026-11-08 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-002 | NPP | 2027-06-12 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 2 captures of this ZIP | 2024-11 | N202293-002 | PED | 2027-12-12 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N202293-001 | I-857 | 2024-04-30 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N202293-001 | M-298 | 2026-05-08 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N202293-001 | PED | 2026-11-08 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N202293-001 | NPP | 2027-06-12 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N202293-001 | PED | 2027-12-12 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N202293-002 | I-857 | 2024-04-30 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N202293-002 | M-298 | 2026-05-08 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N202293-002 | PED | 2026-11-08 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N202293-002 | NPP | 2027-06-12 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N202293-002 | PED | 2027-12-12 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202293-001 | I-857 | 2024-04-30 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202293-001 | M-298 | 2026-05-08 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202293-001 | PED | 2026-11-08 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202293-001 | NPP | 2027-06-12 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202293-001 | PED | 2027-12-12 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202293-002 | I-857 | 2024-04-30 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202293-002 | M-298 | 2026-05-08 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202293-002 | PED | 2026-11-08 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202293-002 | NPP | 2027-06-12 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N202293-002 | PED | 2027-12-12 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N202293-001 | I-857 | 2024-04-30 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N202293-001 | M-298 | 2026-05-08 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N202293-001 | PED | 2026-11-08 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N202293-001 | NPP | 2027-06-12 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N202293-001 | PED | 2027-12-12 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N202293-002 | I-857 | 2024-04-30 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N202293-002 | M-298 | 2026-05-08 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N202293-002 | PED | 2026-11-08 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N202293-002 | NPP | 2027-06-12 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N202293-002 | PED | 2027-12-12 | 301d65b070ca… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FARXIGA | DAPAGLIFLOZIN | A-S Medication Solutions | 01f90c94-71cb-4a1f-81ff-8004b850529b | 2026-07-10 | Warnings, Adverse reactions | 202293 NDA202293 |
| FARXIGA | DAPAGLIFLOZIN | AstraZeneca Pharmaceuticals LP | 72ad22ae-efe6-4cd6-a302-98aaee423d69 | 2026-06-03 | Warnings, Adverse reactions | 202293 NDA202293 |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | Prasco Laboratories | 3aba33aa-f8c6-4b10-85c8-dfa14578d07c | 2026-06-03 | Warnings, Adverse reactions | 202293 NDA202293 66993-457 |
| FARXIGA | DAPAGLIFLOZIN | REMEDYREPACK INC. | ef9e9c8c-5460-4193-952a-0c249dd071bd | 2026-04-24 | Warnings, Adverse reactions | 202293 NDA202293 |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | Bryant Ranch Prepack | 979205ee-b0b8-4483-ae61-f283f750bb7f | 2024-08-08 | Warnings, Adverse reactions | 202293 NDA202293 |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | A-S Medication Solutions | 82cdd5ad-df2b-4bdd-a3a6-a059040100b4 | 2024-06-28 | Warnings, Adverse reactions | 202293 NDA202293 |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | A-S Medication Solutions | 87521963-0d2a-4a2a-89c6-d50e8582419e | 2024-06-28 | Warnings, Adverse reactions | 202293 NDA202293 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- DAPAGLIFLOZIN
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DAPAGLIFLOZIN PROPANEDIOL | 10 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 887K2391VH | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3aba33aa-f8c6-4b10-85c8-dfa14578d07c | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c30aab5e-c89f-4b59-83b1-99a940b63351 | Product name | 1 | 20200925 |
| 1dc427fa-8c3b-4309-981e-ea1ff01326e5 | Product name | 1 | 20190731 |
| 85b4e38c-4488-4e48-919e-244e107d9bd9 | Product name | 2 | 20190731 |
| 5ec207a9-fa56-4ff7-8fae-9a7d9a6bf52c | Product name | 2 | 20170824 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66993-457-30 | DAPAGLIFLOZIN | 30 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 30 | 9 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66993-457-30 | EA - Each | 66993-457 | 9e8ea173-8990-4ad8-8a54-1a11f868ac7b | 1 | 2024-02-14 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 66993-457-30 | 66993045730 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (66993-457-30) | 2024-01-03 | No | No | Current |